Paper · 56009
Selective suppression of immune responses. Regulation of antibody formation and cell-mediated immunity by antibody.
Fitch FW. Prog Allergy, 1975. Cited by 60 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Selective suppression of immune responses. Regulation of antibody formation and cell-mediated immunity by antibody. Papers, record 56009. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/56009
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Selective suppression of immune responses. Regulation of antibody formation and cell-mediated immunity by antibody.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies | Major topic |
| Antibody Formation | Major topic |
| Immunity, Cellular | Major topic |
| Immunosuppression Therapy | Major topic |
| Animals | |
| B-Lymphocytes | |
| Binding, Competitive | |
| Epitopes | |
| Feedback | |
| Immune Sera | |
| Immunity, Maternally-Acquired | |
| Immunoglobulin Fc Fragments | |
| Immunoglobulin G | |
| Immunoglobulin M | |
| Mice | |
| Rats | |
| Receptors, Drug | |
| T-Lymphocytes |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 10,540,225 | Regulation of VH gene repertoire and somatic mutation in germinal centre B cells by passively administered antibody. | Immunology | 1999 | https://conductscience.org/library/papers/10540225 | PubMed |
| 7,439,980 | Suppression of the intestinal immune response to cholera toxin by specific serum antibody. | Infect Immun | 1980 | https://conductscience.org/library/papers/7439980 | PubMed |
| 6,444,664 | Feedback suppression of the immune response in vitro. II. IgVH-restricted antibody-dependent suppression. | J Exp Med | 1980 | https://conductscience.org/library/papers/6444664 | PubMed |
| 6,444,663 | Feedback suppression of the immune response in vitro. I. Activity of antigen-stimulated B cells. | J Exp Med | 1980 | https://conductscience.org/library/papers/6444663 | PubMed |
| 6,236,151 | T suppressor cells as well as anti-hapten and anti-idiotype B lymphocytes regulate contact sensitivity to oxazolone in mice injected with purified protein derivative from Mycobacterium tuberculosis. | Infect Immun | 1984 | https://conductscience.org/library/papers/6236151 | PubMed |
| 6,217,153 | Anti-idiotype regulation of the formation of IgE antibody to timothy grass pollen. II. In vitro induction of suppressor T cells in mini-Marbrook cultures. | Immunology | 1983 | https://conductscience.org/library/papers/6217153 | PubMed |
| 6,212,537 | Anti-idiotype regulation of timothy grass pollen IgE antibody formation. I. In vivo induction of suppressor T cells. | Immunology | 1982 | https://conductscience.org/library/papers/6212537 | PubMed |
| 2,949,381 | Mechanisms of physiologic B cell responses and B cell hyperactivity in systemic lupus erythematosus. | Springer Semin Immunopathol | 1986 | https://conductscience.org/library/papers/2949381 | PubMed |
| 355,125 | Direct blockade of antigen-reactive B lymphocytes by immune complexes. An 'off' signal for precursors of IgM-producing cells provided by the linkage of antigen-and Fc-receptors. | Immunology | 1978 | https://conductscience.org/library/papers/355125 | PubMed |
| 321,357 | Escape from antibody-mediated immune suppression in vitro by delayed-type hypersensitivity reaction. | Infect Immun | 1977 | https://conductscience.org/library/papers/321357 | PubMed |
1 to 10 of 13
See all 13 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/56009
GET https://conductscience.org/api/papers/v1/56009/authors